Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Price

Showing results (971-980 of 991) with videos related to

Pageof 100
Sort By:
Malaria Journal|November 14, 2025
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysisPeta Edler, Megha Rajasekhar, David J Price, et al.
Nature Communications|May 25, 2017
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistancePaul M O'Neill, Richard K Amewu, Susan A Charman, et al.
BMC Medicine|August 2, 2019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Nature Communications|October 24, 2020
General destabilizing effects of eutrophication on grassland productivity at multiple spatial scalesYann Hautier, Pengfei Zhang, Michel Loreau, et al.
The Lancet. Infectious Diseases|July 24, 2018
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Malaria Journal|April 7, 2017
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working GroupKamala Thriemer, Benedikt Ley, Albino Bobogare, et al.
Communications Biology|December 23, 2022
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malariaHidayat Trimarsanto, Roberto Amato, Richard D Pearson, et al.
Frontiers in Neuroscience|June 9, 2022
The Developing Human Connectome Project Neonatal Data ReleaseA David Edwards, Daniel Rueckert, Stephen M Smith, et al.
Pageof 100

Showing results (971-980 of 991) with videos related to

Sort By:
Pageof 100
Malaria Journal|November 14, 2025
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysisPeta Edler, Megha Rajasekhar, David J Price, et al.
Nature Communications|May 25, 2017
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistancePaul M O'Neill, Richard K Amewu, Susan A Charman, et al.
BMC Medicine|August 2, 2019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Nature Communications|October 24, 2020
General destabilizing effects of eutrophication on grassland productivity at multiple spatial scalesYann Hautier, Pengfei Zhang, Michel Loreau, et al.
The Lancet. Infectious Diseases|July 24, 2018
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Malaria Journal|April 7, 2017
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working GroupKamala Thriemer, Benedikt Ley, Albino Bobogare, et al.
Communications Biology|December 23, 2022
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malariaHidayat Trimarsanto, Roberto Amato, Richard D Pearson, et al.
Frontiers in Neuroscience|June 9, 2022
The Developing Human Connectome Project Neonatal Data ReleaseA David Edwards, Daniel Rueckert, Stephen M Smith, et al.
Pageof 100